Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Tyler Torrico

Biographic Data

ID7958313
NAMETyler Torrico
GIVEN NAMESTyler
FAMILY NAMETorrico
SIGNATURETORRICO T
AFFILIATIONSKern Medical Center
ORCID0000-0002-4817-8380
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Presence of kratom in opioid overdose deaths

    Open Access•Tyler Torrico, Kajal Patel et al.•ARTICLE•Frontiers in Psychiatry•2024

    The findings of this brief report provide insight into the role that mitragynine (kratom) may have in modulating risk of opioid-related deaths. The combined use of kratom with opioids such as fentanyl appears most likely to increase the risk of a fatal overdose, but it may also occur with other medications such as benzodiazepines and psychiatric medications. It is a serious concern that in the midst of the opioid overdose epidemic there is a grow…

  • Educating the next generation of psychiatrists in the use of clinical neuromodulation therapies

    Open Access•Sahit N Menon, Tyler Torrico et al.•ARTICLE•Frontiers in Psychiatry•2024

    A variety of neuromodulation treatments are available today and more are on the way, but are tomorrow's psychiatrists prepared to incorporate these tools into their patients' care plans? This article addresses the need for training in clinical neuromodulation for general psychiatry trainees. To ensure patient access to neuromodulation treatments, we believe that general psychiatrists should receive adequate education in a spectrum of neuromodulat…

  • Pathophysiology and management of risperidone-induced sialorrhea

    Open Access•Tyler Torrico, Angad Kahlon•ARTICLE•Frontiers in Psychiatry•2023

    The pathophysiology of antipsychotic-induced sialorrhea is complex and varies between antipsychotics. Risperidone-induced sialorrhea is suspected of having prominent adrenergic pathophysiology that is likely composed of highly viscoelastic saliva (high protein content), differing from the more commonly encountered clozapine-induced sialorrhea. Risperidone-induced sialorrhea is reported as more likely to respond to dose reduction and treatment wit…

  • Worsening psychosis associated with administrations of buspirone and concerns for intranasal administration

    Open Access•Samuel Apeldoorn, Rebecca Chavez et al.•ARTICLE•Frontiers in Psychiatry•2023

    Buspirone is commonly used to treat generalized anxiety disorder and demonstrates a limited side-effect profile compared to other anxiolytics. Buspirone is considered generally safe, and neuropsychiatric adverse reactions are uncommon. There are rare clinical case reports that suggest buspirone-induced psychosis. We present a case of buspirone worsening psychosis for a patient psychiatrically hospitalized for an episode of decompensated schizoaff…

  • The pathophysiology of rapid fluctuations in mental status associated with olanzapine

    Open Access•Tyler Torrico, Tyler J Torrico•ARTICLE•Frontiers in Psychiatry•2022

    Rapid fluctuations in mental status between somnolence and agitation are not clearly described among other antipsychotics, and it is possible that this phenomenon may be specific to olanzapine. The findings of this case report suggested that this phenomenon was likely the result of the oversaturation of (H 1 ) and (M 1 ) receptors

  • Postinfectious Covid-19 Catatonia

    Open Access•Tyler Torrico, Timothy Kiong et al.•ARTICLE•Frontiers in Psychiatry•2021

    Neuropsychiatric symptoms are a common complication of COVID-19, with symptoms documented both during acute COVID-19 infection (parainfectious) and persisting or developing after the resolution of respiratory symptoms (postinfectious). Patients have presented with a variety of symptoms such as anosmia, thrombotic events, seizures, cognitive and attention deficits, new-onset anxiety, depression, psychosis, and rarely catatonia. Etiology appears to…

  • Clozapine-Induced Pneumonitis

    Open Access•Tyler Torrico, Ronald O Crandall et al.•ARTICLE•Frontiers in Psychiatry•2020

    Introduction: Clozapine is the most effective antipsychotic used for treatment resistant schizophrenia and recurrent suicidal behavior in schizophrenia or schizoaffective disorder. However, it has been underutilized due to its adverse reaction profile. Although clozapine is typically associated with neutropenia leading to increased risk of infection (i.e., pneumonia), there have been a few case reports of non-neutropenic, non-infectious drug-indu…

No prominent works on this page.

  • Clozapine-Induced Pneumonitis

    Open Access•Tyler Torrico, Ronald O Crandall et al.•ARTICLE•Frontiers in Psychiatry•2020

    Introduction: Clozapine is the most effective antipsychotic used for treatment resistant schizophrenia and recurrent suicidal behavior in schizophrenia or schizoaffective disorder. However, it has been underutilized due to its adverse reaction profile. Although clozapine is typically associated with neutropenia leading to increased risk of infection (i.e., pneumonia), there have been a few case reports of non-neutropenic, non-infectious drug-indu…

  • Postinfectious Covid-19 Catatonia

    Open Access•Tyler Torrico, Timothy Kiong et al.•ARTICLE•Frontiers in Psychiatry•2021

    Neuropsychiatric symptoms are a common complication of COVID-19, with symptoms documented both during acute COVID-19 infection (parainfectious) and persisting or developing after the resolution of respiratory symptoms (postinfectious). Patients have presented with a variety of symptoms such as anosmia, thrombotic events, seizures, cognitive and attention deficits, new-onset anxiety, depression, psychosis, and rarely catatonia. Etiology appears to…

  • The pathophysiology of rapid fluctuations in mental status associated with olanzapine

    Open Access•Tyler Torrico, Tyler J Torrico•ARTICLE•Frontiers in Psychiatry•2022

    Rapid fluctuations in mental status between somnolence and agitation are not clearly described among other antipsychotics, and it is possible that this phenomenon may be specific to olanzapine. The findings of this case report suggested that this phenomenon was likely the result of the oversaturation of (H 1 ) and (M 1 ) receptors

  • Pathophysiology and management of risperidone-induced sialorrhea

    Open Access•Tyler Torrico, Angad Kahlon•ARTICLE•Frontiers in Psychiatry•2023

    The pathophysiology of antipsychotic-induced sialorrhea is complex and varies between antipsychotics. Risperidone-induced sialorrhea is suspected of having prominent adrenergic pathophysiology that is likely composed of highly viscoelastic saliva (high protein content), differing from the more commonly encountered clozapine-induced sialorrhea. Risperidone-induced sialorrhea is reported as more likely to respond to dose reduction and treatment wit…

  • Worsening psychosis associated with administrations of buspirone and concerns for intranasal administration

    Open Access•Samuel Apeldoorn, Rebecca Chavez et al.•ARTICLE•Frontiers in Psychiatry•2023

    Buspirone is commonly used to treat generalized anxiety disorder and demonstrates a limited side-effect profile compared to other anxiolytics. Buspirone is considered generally safe, and neuropsychiatric adverse reactions are uncommon. There are rare clinical case reports that suggest buspirone-induced psychosis. We present a case of buspirone worsening psychosis for a patient psychiatrically hospitalized for an episode of decompensated schizoaff…

  • Presence of kratom in opioid overdose deaths

    Open Access•Tyler Torrico, Kajal Patel et al.•ARTICLE•Frontiers in Psychiatry•2024

    The findings of this brief report provide insight into the role that mitragynine (kratom) may have in modulating risk of opioid-related deaths. The combined use of kratom with opioids such as fentanyl appears most likely to increase the risk of a fatal overdose, but it may also occur with other medications such as benzodiazepines and psychiatric medications. It is a serious concern that in the midst of the opioid overdose epidemic there is a grow…

  • Educating the next generation of psychiatrists in the use of clinical neuromodulation therapies

    Open Access•Sahit N Menon, Tyler Torrico et al.•ARTICLE•Frontiers in Psychiatry•2024

    A variety of neuromodulation treatments are available today and more are on the way, but are tomorrow's psychiatrists prepared to incorporate these tools into their patients' care plans? This article addresses the need for training in clinical neuromodulation for general psychiatry trainees. To ensure patient access to neuromodulation treatments, we believe that general psychiatrists should receive adequate education in a spectrum of neuromodulat…

Medicine (7 works) · Psychiatry (7 works) · Internal Medicine (5 works) · Psychology (5 works) · Schizophrenia (object-oriented programming (5 works) · Psychosis (3 works) · Schizophrenia research and treatment (3 works) · Anesthesia (2 works) · Antipsychotic (2 works) · Clozapine (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae